PMA supplement
P840012 S007: LASAG MICRORUPTOR III Q-SWITCH ND:YAG
FDA PMA supplement · Normal 180 Day Track · Meridian AG
Key facts
| Original PMA | P840012 |
|---|---|
| Supplement number | S007 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | LASAG MICRORUPTOR III Q-SWITCH ND:YAG |
| Generic name | Laser, neodymium:Yag, ophthalmic for uses other than posterior capsulotomy & cutting pupillary |
| Applicant | Meridian AG |
| Product code | LOI |
| Received date | Dec 20, 1989 |
| Decision date | Apr 5, 1991 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: